Skip to main content
OpenTrials

Clinical trial condition

Stargardt's Macular Dystrophy

Explore clinical trials studying Stargardt's Macular Dystrophy. Study availability and eligibility vary by location and protocol.

6 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Stargardt's Macular Dystrophy trial results

Completed

Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

NCT03364153

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Retinal Research Institute Phoenix, Arizona, United States
  • Jules Stein Eye Institute/ David Geffen School of Medicine Los Angeles, California, United States
  • VitreoRetinal Associates Gainesville, Florida, United States
  • Retina Specialty Institute Pensacola, Florida, United States
View all 41 locations
View Trial Details
Completed

Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy

NCT01345006

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Jules Stein Eye Institute, UCLA School of Medicine Los Angeles, California, United States
  • Bascom Palmer Eye institute Miami, Florida, United States
  • Wills Eye Institute-Mid Atlantic Retina Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Stargardt Macular Dystrophy Patients

NCT02445612

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Jules Stein Eye Institute, UCLA School of Medicine Los Angeles, California, United States
  • Bascom Palmer Eye Institute Miami, Florida, United States
  • Wills Eye Institute-Mid Atlantic Retina Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

NCT01469832

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Lothian Health Board Headquarters at Waverley Gate Edinburgh, United Kingdom
  • Moorefields Eye Hospital NHS Foundation Trust London, United Kingdom
  • Newcastle on Tyne NHS Foundation Trust Newcastle upon Tyne, United Kingdom
View Trial Details
Completed

A Follow up Study to Determine the Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

NCT02941991

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +6 more
Locations
  • Moorefields Eye Hospital NHS Foundation Trust London, United Kingdom
  • Newcastle on Tyne NHS Foundation Trust Newcastle upon Tyne, United Kingdom
View Trial Details

Related conditions